VanEck Associates’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.42M Buy
50,501
+1,081
+2% +$116K 0.01% 697
2025
Q1
$4.99M Sell
49,420
-9,564
-16% -$965K 0.01% 713
2024
Q4
$5.27M Buy
58,984
+1,090
+2% +$97.4K 0.01% 677
2024
Q3
$5.06M Buy
57,894
+8,882
+18% +$777K 0.01% 639
2024
Q2
$3.77M Buy
49,012
+2,541
+5% +$196K 0.01% 685
2024
Q1
$3.18M Sell
46,471
-5,934
-11% -$406K ﹤0.01% 727
2023
Q4
$3.03M Buy
52,405
+1,659
+3% +$95.9K 0.01% 681
2023
Q3
$2.68M Sell
50,746
-1,435
-3% -$75.8K 0.01% 673
2023
Q2
$2.82M Sell
52,181
-254
-0.5% -$13.7K 0.01% 646
2023
Q1
$2.62M Sell
52,435
-2,752
-5% -$138K 0.01% 632
2022
Q4
$2.55M Buy
55,187
+1,692
+3% +$78.3K 0.01% 622
2022
Q3
$2.07M Buy
53,495
+4,910
+10% +$190K 0.01% 637
2022
Q2
$1.81M Buy
48,585
+1,966
+4% +$73.3K ﹤0.01% 679
2022
Q1
$2.07M Sell
46,619
-3,247
-7% -$144K ﹤0.01% 698
2021
Q4
$2.12M Buy
49,866
+32,844
+193% +$1.4M ﹤0.01% 707
2021
Q3
$739K Buy
17,022
+1,262
+8% +$54.8K ﹤0.01% 865
2021
Q2
$674K Sell
15,760
-24
-0.2% -$1.03K ﹤0.01% 870
2021
Q1
$610K Buy
15,784
+3,887
+33% +$150K ﹤0.01% 823
2020
Q4
$428K Hold
11,897
﹤0.01% 791
2020
Q3
$455K Sell
11,897
-513
-4% -$19.6K ﹤0.01% 751
2020
Q2
$436K Sell
12,410
-7,388
-37% -$260K ﹤0.01% 737
2020
Q1
$646K Sell
19,798
-17,349
-47% -$566K ﹤0.01% 648
2019
Q4
$1.68M Buy
37,147
+1,513
+4% +$68.4K 0.01% 543
2019
Q3
$1.45M Buy
35,634
+2,984
+9% +$121K 0.01% 525
2019
Q2
$1.4M Buy
32,650
+15,568
+91% +$669K 0.01% 522
2019
Q1
$656K Buy
+17,082
New +$656K ﹤0.01% 648